Skip to content

OMDA OMDA Amortization of deferred commissions

Amortization of deferred commissions at other companies

Hinge Health, Inc. logo
Hinge Health, Inc.HNGE

Other financials

Income statement

See full
Revenue$78.0M+42.0%
Gross profit$48.7M+52.6%
Operating income-$4.8M+43.1%
Net income-$3.0M+68.6%
EPS (diluted)-$0.05+95.7%

Balance sheet

See full
Cash & equivalents$211.8M+257%
Total debt$30.0M
Total equity$234.1M+160%
Total assets$302.8M

Cash flow

See full
Operating cash flow-$11.8M+26.6%
CapEx$78.0K-75.2%
Free cash flow-$11.9M+27.5%

Valuation

See full
Market cap$1.11B+23.8%
P/S3.9×-0.4×

Profitability

See full
Gross margin66.3%+4.4pp
Operating margin-9.6%-4.0pp
Net margin-11.3%-4.6pp
FCF margin-40.8%

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.1×
Current ratio3.9×

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDeferredSalesCommissions.

The official record: OMDA’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's amortization of deferred commissions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OMDA's amortization of deferred commissions?
OMDA (OMDA) reported amortization of deferred commissions of $958K in Q1 2026.
How has OMDA's amortization of deferred commissions changed year-over-year?
OMDA's amortization of deferred commissions increased by 30.5% year-over-year, from $734K to $958K.